Why Do Wall Street Analysts Rarely Say Sell?
Fewer than 3 in 100 recent analyst ratings were sells. Here is the data, the incentives behind it, and how to read a rating scale that leans so heavily toward buy.
The evidence on analyst optimism, where the conflicts come from, what regulation changed, and how to correct for the bias when you read a rating.
Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →
Yes, on average they lean bullish. The clearest sign is the rating mix: buys outnumber sells by about 24 to 1 in Exent’s data. The second sign is price targets, which are set above the current price most of the time and are reached only about half the time.
| Measure (Exent’s 7-year backtest) | Value |
|---|---|
| Ratings analysed | 988,127 from the 1,191 analysts in Exent’s ranking |
| Buy / Hold / Sell, last 12 months | 70.4% / 26.6% / 3.0% |
| Price targets reached within 12 months (average analyst) | 53.0%, across 820,838 calls with a target |
| Average implied upside when the target was set | 66.0% |
| Median 12-month price return after a call | +13.6% |
Statistics as of Nov 16, 2026. The implied upside is an average, so a minority of very large targets pulls it up; the gap to realized returns is still wide. Our study of how accurate price targets are breaks these numbers down.
Sell-side analysts work for banks and brokers whose revenue does not come from the accuracy of the research itself. Five pressures follow from that.
| Pressure | How it tilts ratings |
|---|---|
| Investment banking | Firms want to win the company’s deals; a negative rating does not help |
| Management access | Analysts rely on company calls and meetings that a harsh view can jeopardize |
| Trading revenue | Buy ideas generate more client trading than sell ideas |
| Career incentives | Optimism has been linked to better job moves |
| Coverage choice | Analysts pick up stocks they like and drop the rest quietly |
The difference between who pays and who reads is covered in sell-side vs buy-side.
A long line of research documents it. Some of the most cited findings:
Bank disclosures show the link to banking business directly. In J.P. Morgan’s ratings disclosure as of June 30, 2014, 75% of the US broker’s Overweight-rated companies had been investment banking clients in the prior 12 months, against 54% of its Underweight-rated ones. That does not prove any single rating was biased. It shows why rules require the disclosure.
They forced a wall between research and banking. In 2003, ten firms settled with the SEC, NASD, NYSE and state regulators for roughly $1.4 billion in the Global Research Analyst Settlement, without admitting or denying the allegations. Two star analysts were barred for life: Henry Blodget, who paid $4 million, and Jack Grubman, who paid $15 million.
Today FINRA Rule 2241 bars paying analysts for specific banking deals, stops bankers from supervising analysts, and requires each report to disclose the firm’s buy, hold and sell distribution. The rules reduced the most blatant conflicts. The rating mix in the same data shows the optimistic tilt remains.
No. A biased signal can still be informative if you know the direction of the bias. Two findings matter most. First, changes carry more information than levels: an upgrade or downgrade says more than a standing buy. Second, analysts differ enormously. In the same data, 56 ranked analysts had price-target hit rates of 80% or more, while 99 were below 30%.
So the practical fix is not to ignore analysts. It is to discount the average and weight the individual by track record. See how to judge an analyst and the most accurate stock analysts study.
Across 988,127 ratings, the average Wall Street analyst’s price target was reached 53.0% of the time: close to a coin flip. The spread between analysts is wide, and 14.4% of the 971 analysts with a measurable record reached 70% or more (Exent data, Nov 16, 2026).
Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.
Public analyst rankings that score analysts on how their past calls played out make the last point practical. Related: why analysts rarely say sell.
Yes. In Exent’s data, 70.4% of ratings issued in the 12 months to Nov 16, 2026 were Buy and only 3.0% were Sell.
Targets reflect the same optimism as ratings. Research on 2000 to 2009 targets found target-implied returns exceeded actual returns by 15% on average, and Exent’s data shows the average analyst’s targets were reached within 12 months only 53.0% of the time.
It reduced the most direct conflicts by separating research from investment banking and requiring disclosures. Ratings still lean heavily toward buy.
They lack investment banking conflicts, and a 1999 study found affiliated analysts’ buy calls on IPOs did worse than those of unaffiliated brokers. Independence removes one source of bias, not all of them.
Look at the analyst’s own record: how often past price targets were reached, how often stocks rose after their calls, and over how many calls. Accuracy varies widely between analysts.
Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.